Connect with us

Health

WHO Study Finds Remdesivir Didn’t Help COVID-19 Patients

Published

on

The WHO's latest report finds Remdesivir did nothing to improve patients' COVID-19 conditions. Photo: Sascha Steinbach/EPA.

GENEVA (AP) — A large study led by the World Health Organization suggests that the antiviral drug remdesivir did not help hospitalized COVID-19 patients, in contrast to an earlier study that made the medicine a standard of care in the United States and many other countries.

The results announced Friday do not negate the previous ones, and the WHO study was not as rigorous as the earlier one led by the U.S. National Institutes of Health. But they add to concerns about how much value the pricey drug gives because none of the studies have found it can improve survival.

The drug has not been approved for COVID-19 in the U.S., but it was authorized for emergency use after the previous study found it shortened recovery time by five days on average. It’s approved for use against COVID-19 in the United Kingdom and Europe, and is among the treatments U.S. President Donald Trump received when he was infected earlier this month.

The WHO study involved more than 11,000 patients in 30 countries. About 2,750 were randomly assigned to get remdesivir. The rest got either the malaria drug hydroxychloroquine, the immune-system booster interferon, the antiviral combo lopinavir-ritonavir, or just usual care. The other drugs have largely been ruled out for COVID-19 by previous studies, but not remdesivir.

Death rates after 28 days, the need for breathing machines and time in the hospital were relatively similar for those given remdesivir versus usual care.

The results have not been published in a journal or reviewed by independent scientists, but were posted on a site researchers use to share results quickly.

“The big story is the finding that remdesivir produces no meaningful impact on survival,” Martin Landray, an Oxford University professor who led other coronavirus treatment research, said in a statement.

“This is a drug that has to be given by intravenous infusion for five to 10 days,” and costs about $2,550 per treatment course, he said. “COVID affects millions of people and their families around the world. We need scalable, affordable and equitable treatments.”

Dr. Margaret Harris, a WHO spokeswoman, attributed the difference in the conclusions of the two studies to the fact WHO’s was larger.

“It’s just a much higher-powered study,” she said. “It’s quadruple the number of people in all the other studies.”

However, Dr. Andre Kalil, a University of Nebraska infectious disease specialist who helped lead the U.S. remdesivir study, said the WHO one was poorly designed, which makes its conclusions less reliable. Patients and doctors knew what treatment they were using, there was no placebo infusion to help avoid biased reporting of risks or benefits, there was little information about the severity of patients’ symptoms when treatments began and a lot of missing data, he said.

“Poor quality study design cannot be fixed by a large sample size, no matter how large it is,” Kalil wrote in an email.

Furthermore, the WHO study tested 10 days of remdesivir, so some patients may have been hospitalized longer than they needed to be just to finish treatment, making their length of stay look bad in comparison to others getting usual care.

Remdesivir’s maker, Gilead Sciences, said in a statement that the results are inconsistent with more rigorous studies and have not been fully reviewed or published.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published.

Health

PBIRx Launches “PBIRx Success Stories” Video Series Featuring Client Case Study Testimonials

Published

on

MILFORD, Conn.–(BUSINESS WIRE)–PBIRx, Inc., a leading pharmacy benefit auditing and consulting firm, is excited to announce the launch of its new video series, PBIRx Success Stories. These client testimonial videos highlight the successful partnerships between PBIRx and its valued client partners. In this insightful series, clients share their experiences working with PBIRx’s team of skilled account consultants, PharmDs, and analysts to achieve substantial plan cost savings, reduce drug trends, and enhance member outcomes and satisfaction.

“We value their trust and strive to educate”

The first two videos in the PBIRx Success Stories series spotlight the successful partnership of PBIRx and two Taft-Hartley groups, featuring Tim Morrin, Fund Administrator of Automatic Sprinkler Local 281, U.A. Welfare Fund, and Phyllis Lucidi, Health Plans Administrator of Teamsters Local 35 Health Plans. Both commend PBIRx for delivering tangible results to their plan and employing unique strategies to optimize savings while protecting their members’ quality of care.

“With the savings from PBIRx, we are certainly helping our bottom line. We are improving our financial footing and building our reserves,” said Tim Morrin, Fund Administrator of Automatic Sprinkler Local 281, U.A. Welfare Fund. “The results were a million-dollar savings, 25 percent from the year previous, and we couldn’t be more pleased at the results and the savings that we got with this partnership.

“We haven’t raised our copays in years. We would like to continue to offer those low costs so that these families that are part of our local union can prosper,” Morrin added. “These are working families that are experiencing inflation.”

The PBIRx Success Stories series showcases real-life examples of how PBIRx has successfully helped numerous clients save on pharmacy benefit costs without compromising the quality of care provided to their members.

“PBIRx takes great pride in the partnerships we cultivate with our clients,” said Patricia Sirowich, PBIRx Founder and President, “and we are very grateful for the testimonials shared on our behalf by our valued client partners.

“We value their trust and strive to educate,” Sirowich said. “We see ourselves as a guide, taking our clients by the hand and leading them through the complex maze of the pharmacy benefit landscape and shining a light of transparency on Pharmacy Benefit Managers (PBM) and pharmaceutical manufacturers and the tactics they employ to achieve excessive profits.”

“I know where my costs are and I see our plan is doing fantastic,” said Phyllis Lucidi, Health Plans Administrator of Teamsters Local 35 Health Plans. “We have a reserve that is unheard of today. Service is excellent. We can call them at any time. Our answers are at our fingertips.

“I would most definitely recommend PBIRx and for many reasons. Their reliability, their service, the value that they have brought to Teamsters 35 is of the utmost highest quality,” Lucidi added. “That’s important to our members and their families today.”

To view the “PBIRx Success Stories” video series, visit PBIRx.com.

Continue Reading

Health

iHerb® and NFL Alumni Health Team Up to Provide Valuable Membership Perks

Published

on

NFL Alumni Official, Mike Brodsky, Host and Associate Editor of Super Bowl Events for Florida National News, iHerb Global Advisor Dr. Mehmet Oz, Bill Davis, NFL Alumni Health, and Kyle Richardson, NFL Alumni visits Super Bowl LVIII Radio Row at the Mandalay Bay Convention Center, Wednesday, February 7, 2024. Brion Price / Florida National News

IRVINE, Calif., Feb. 7, 2024 /PRNewswire/ — iHerb, one of the world’s leading e-commerce retailers for vitamins, minerals, supplements and other health and wellness products, announced a strategic alliance with the National Football League Alumni Association to offer its members and the general public access to a curated selection of wellness products.

To promote the newly formed partnership, iHerb Global Advisor Dr. Mehmet Oz was a featured speaker at the “Huddle for Health” NFL Alumni Health Symposium held Feb. 6 in Las Vegas. With numerous members and guests in attendance, Dr. Oz discussed the essential role vitamins and nutrients play in extending one’s longevity.

“One of the primary reasons our nonprofit organization exists is to help ensure the long-term health of our members,” said NFL Alumni CEO Brad Edwards. “As iHerb and Dr. Oz work together to make health and wellness more accessible, our members and supporters can access this platform as a crucial component of taking a proactive approach to optimizing their health and improving their overall well-being.”

Starting today, NFL Alumni members and fans are eligible for up to 15% off iHerb orders of $60 or more using promo code “NFLALUMNI.” As part of the NFL Alumni’s “Get What the Pros Get” initiative, iHerb is extending the “NFLALUMNI” promo code to the public for a limited time. A portion of the proceeds from each order will help the NFL Alumni advance its support of community organizations that serve children and families in need.

iHerb is proud to join other health and wellness providers that offer information, resources and tools to help NFL Alumni members enhance their quality of life long after their time on the field.

To learn more about the NFL Alumni and its charitable partners, please click here. To view all press releases from iHerb, please visit: iherb.com/pressreleases.

About iHerb:
iHerb is one of the world’s leading e-commerce destinations dedicated to offering a vast selection of vitamins, minerals, supplements and other health and wellness products. Supported by a global workforce of 3,000 team members, iHerb serves more than 10 million global active customers across more than 180 countries and 19 languages. iHerb’s sophistical global logistics network is anchored by eight climate-controlled fulfillments centers located in the U.S. and Asia, providing customers a seamless and reliable shopping experience. Founded in 1996 and based in Irvine, California, iHerb is on a mission to make health and wellness accessible to all. For more information, please visit corporate.iherb.com.

About NFL Alumni (NFLA):
NFLA is an organization with a nationwide reach comprised primarily of National Football League players, coaches, and other employees whose mission since 1967 is “Caring for our Own” and “Caring for Kids.” The mission of the NFLA is furthered by numerous efforts, including raising funds to support its members, their communities, and qualified youth-oriented charities. NFL Alumni Health is a wholly owned subsidiary of NFL Alumni, offering informational resources, programs, services, and other offerings for NFL Alumni members and the general public.

Continue Reading

Health

Being Health Launches With $5.4 Million in Funding and a Mission to Bring the Best of Psychiatry and Novel Treatments Under One Roof

Published

on

Being Health Reception. Credit: Alexandra Rowley

NEW YORK–(BUSINESS WIRE)–Being Health, a psychiatrist-founded modern mental health practice, launches today to bring the best of psychiatry, psychotherapy, novel treatments (such as ketamine infusion therapy), functional medicine and wellness services (such as acupuncture and nutrition) all under one roof for a seamless patient experience in New York City. Being Health has raised $5.4 million to date in funding from 18 Park and HDS Capital.

“Opportunities for enhancing the mental health care system are rapidly expanding and we see ourselves at the forefront of these innovations”

In a world that offers one-size-fits-all solutions, Being Health was created for patients who desire a truly personalized approach to mental health care that emphasizes the impact of both mind and body on a person’s well-being. Being Health offers a multi-dimensional approach and provides access to a diversity of evidence-based treatments to patients experiencing anxiety, depression, trauma, and stress.

Co-founded and led by Cornell-trained psychiatrist Dr. Allie Sharma, Being Health’s care team includes a diverse array of clinicians – such as psychiatrists, psychotherapists, nurse anesthetists (CRNAs), functional medicine physicians, nutritionists, acupuncturists and care advocates – all working together to provide exceptional patient care and better patient outcomes.

“We are combining the best of what is tried and tested in psychiatry with what is new and novel in our field,” said Dr. Allie Sharma, Being Health co-founder and Chief Medical Officer. “More and more Americans are grappling with mental health conditions, with far too many feeling overwhelmed by the burden of navigating their own care. At Being Health we’ve created a modern mental health practice that seamlessly incorporates a diversity of therapeutic approaches including, for example, ketamine infusion therapy for treatment resistant depression or functional medicine combined with nutritional support to optimize both health and mental health outcomes, which we know are inextricably linked.”

Being Health’s modern mental health practice is guided by empathic clinicians and clinical excellence under the leadership of Medical Director Dr. Hudson Elmore. With multiple disciplines offered under one roof, Being Health’s team of clinicians collaborate with each other to personalize care according to individual needs, offering the potential for optimized mental health outcomes.

“Being Health’s integrated model of care leveraging traditional and novel treatments is positioned to play a leading role in transforming mental health care as we know it,” said Haim Dabah, founder of HDS Capital and lead investor. “By expanding the mental health toolkit and building a team of best-in-class clinicians coupled with gold standard safety protocols, Being Health can serve as a bridge to bring innovative treatments to patients in a safe, clinical environment.

“Today there are more than fifty biotech and pharmaceutical companies investing hundreds of millions of dollars into the development of promising therapeutic applications of novel treatments with approximately thirty clinical trials in Phase II and Phase III with promising results. Upon FDA approval, these novel treatments will likely require delivery to patients in clinically-monitored settings. Being Health is poised to become first-to-market to deliver these novel treatments to patients.”

Being Health offers both in-person and virtual care, with a two-story, 7,000 square foot built-to-suit clinic located in Lower Manhattan at 76 Beaver St. The state-of-the-art facility features 22 spacious rooms for in-person services. New patients can book consultations online at beinghealth.co/book-an-appointment.

“Opportunities for enhancing the mental health care system are rapidly expanding and we see ourselves at the forefront of these innovations,” said Stephen Dabah co-founder & president. “We are creating a new standard for modern mental health care and are developing an ecosystem for the future delivery of novel treatments as they become FDA-approved.”

About Being Health

Co-founded in 2023 by Dr. Allie Sharma, a Cornell trained and board certified Psychiatrist and behavioral health strategist, and Stephen Dabah, a healthcare entrepreneur, Being Health is an integrated mental health practice that leverages the best of psychiatry, novel treatments, psychotherapy, functional medicine and wellness services to personalize care and help people feel better in their everyday state of being. Being Health is setting a new standard for mental health by bringing together diverse therapeutic modalities under one roof. The Being Health team of empathic, highly skilled clinicians collaborates to optimize outcomes for individuals seeking support and treatment across a spectrum of mental health conditions, including anxiety, depression, stress, and trauma. Clinical services are offered virtually and in-person at their clinic in New York City’s Financial District, opening in January 2024. Being Health is committed to fair and transparent pricing, with prices always upfront and no surprise bills or fees. To learn more about Being Health, please visit www.beinghealth.co.

Continue Reading
Advertisement
Advertisement Ticket Time Machine ad
Advertisement Orlando Regional REALTOR Association logo
Advertisement Parts Pass App
Advertisement Hispanic Chamber of Commerce of Metro Orlando
Advertisement
Advertisement African American Chamber of Commerce of Central Florida
Advertisement FNN News en Español
Advertisement Indian American Chamber of Commerce logo
Advertisement Florida Sports Channel

FNN Newsletter

Trending